Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lamprey TFE3 exhibits evolutionarily conserved activation mechanisms and regulates autophagy and immune responses. | Dev Comp Immunol | 2025 | 41052552 | PubTator, text mining | PubMed |
| Successful management of recurrent multiple intracerebral TFE3-rearranged epithelioid hemangioendothelioma with repeated intervention and active surveillance: illustrative case. | J Neurosurg Case Lessons | 2025 | 41052472 | PubTator, text mining | PubMed |
| Targeting chaperone-mediated autophagy to regulate osteoclast activity as a therapeutic strategy for osteoporosis. | Mater Today Bio | 2025 | 41050091 | PubTator, text mining | PubMed |
| Perivascular epithelioid cell tumors of the urinary bladder: a multi-institutional clinicopathologic and molecular analysis of 21 cases. | Virchows Arch | 2025 | 41045311 | PubTator, text mining | PubMed |
| Hyperferritinemia revealing renal carcinoma with TFE3 gene translocation: a rare case report. | Urol Case Rep | 2025 | 41036095 | PubTator, text mining | PubMed |
| RNA-mediated condensation of TFE3 oncofusions facilitates transcriptional hub formation to promote translocation renal cell carcinoma. | Nat Commun | 2025 | 41027885 | PubTator, text mining | PubMed |
| The Prediction of Rare Clear Cell Carcinomas of the Liver via Pathological Component-Based Image Evaluation: A Case Report. | Cureus | 2025 | 41018392 | PubTator, text mining | PubMed |
| Advancing In Vitro Tools for Oncologic Research in Cats and Dogs. | Vet Sci | 2025 | 41012744 | PubTator, text mining | PubMed |
| Renal cell carcinoma unclassified with medullary phenotype: a case report and review of the literature. | Discov Oncol | 2025 | 41003893 | PubTator, text mining | PubMed |
| Developments in Ion Exchange Chromatography-Mass Spectrometry for the Characterization of Intact Proteins and Proteoforms. | J Sep Sci | 2025 | 40976889 | PubTator, text mining | PubMed |
| Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma. | bioRxiv | 2025 | 40950046 | PubTator, text mining | PubMed |
| Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profiling. | bioRxiv | 2025 | 40949957 | PubTator, text mining | PubMed |
| Centrosome dysfunction and autophagy dysregulation in renal cell carcinoma: Implications for tumor progression and therapy. | Hum Pathol | 2025 | 40925490 | PubTator, text mining | PubMed |
| [ALK-rearranged renal cell carcinoma: a clinicopathological analysis of three cases]. | Zhonghua Bing Li Xue Za Zhi | 2025 | 40921669 | PubTator, text mining | PubMed |
| Clinicopathological features, risk model and prognosis of 115 cases of epithelioid hemangioendothelioma: A single-center study. | Front Oncol | 2025 | 40919137 | PubTator, text mining | PubMed |
| Enzalutamide-Resistant STEAP4+ MyoCAF Secrete Phosphatidylcholine to Foster Progression by Activating Stemness in Hormone-Sensitive Prostate Cancer. | Adv Sci (Weinh) | 2025 | 40917018 | PubTator, text mining | PubMed |
| Metastatic pediatric alveolar soft part sarcoma: a rare case report highlighting multidisciplinary treatment, molecular diagnostics, and novel therapeutic approaches. | Front Pediatr | 2025 | 40894409 | PubTator, text mining | PubMed |
| C-terminal fusion partner activity contributes to the oncogenic functions of YAP1::TFE3. | Sci Rep | 2025 | 40887511 | PubTator, text mining | PubMed |
| ATG conjugation-dependent/independent mechanisms underlie lysosomal stress-induced TFEB regulation. | J Cell Biol | 2025 | 40880129 | PubTator, text mining | PubMed |
TFE3-Altered Perivascular Epithelioid Cell Tumour (PEComa) of the Nasal Cavity With a Novel TRAF3::TFE3 Fusion-A Report of a Case Expanding the Molecular Genetic Spectrum and a Brief Literature Review on PEComas of the Head and Neck Region. | Genes Chromosomes Cancer | 2025 | 40879261 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=10